Maraviroc

Medical Advocates
Maraviroc (Selzentry)

Main Page

New and Noteworthy
Journal Data
Conference Data

FDA/EU Approvals
Product Information

Maraviroc Videos

ARV Drugs Main Page

Main New/Newsworthy

Home Page

This web page is best viewed by using INTERNET EXPLORER
Last Update: July 27, 2008

Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

July 2008

Maraviroc: in vitro assessment of drug-drug interaction potential.
Hyland R, Dickins M, Collins C, et al Br J Clin Pharmacol. 2008 Apr 10.
A WEEK IN REVIEW FEATURED REPORT
Maraviroc: new drug. Multiple antiretroviral treatment failure: too soon to reach conclusions.
[No authors listed] Prescrire Int. 2008 Jun;15(33):98-101.

June 2008

FDA/EU Approvals

NEWS RELEASE
Pfizer Receives E.U. Approval of Maraviroc; Monogram Initiates European Operations
Monogram October 01
NEWS RELEASE
FDA Approves Selzentry (Maraviroc) 150 mg and 300 mg Tablets
US FDA August 06, 2007

Maraviroc Videos

Reporting AIDS New HIV Treatment: Maravioc

John Mikytuck sits down with Mark Milano of ACRIA and Dr. Pete Gordon of Columbia University,
to discuss Maraviroc

ARV Drugs Main Page

Main New/Newsworthy

Home Page

Maraviroc (Selzentry ) Main Page